Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Financial Flexibility Index
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of CN¥170.19 Million (operating CF CN¥88.00 Million minus capex CN¥82.19 Million) represents 0% of total liabilities (CN¥1.04 Billion). Check cash flow reinvestment rate of Guangdong Zhongsheng Pharmaceutical Co L to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangdong Zhongsheng Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 002317 cash flow conversion.
Annual Financial Flexibility Index for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Guangdong Zhongsheng Pharmaceutical Co Ltd. Explore how well can Guangdong Zhongsheng Pharmaceutical Co L service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | CN¥566.10 Million | CN¥337.84 Million | CN¥1.54 Billion | ▲ +28.0% |
| 2023 | 0.29x | CN¥553.67 Million | CN¥190.61 Million | CN¥1.93 Billion | ▲ +69.5% |
| 2022 | 0.17x | CN¥331.03 Million | CN¥63.07 Million | CN¥1.96 Billion | ▼ -72.4% |
| 2021 | 0.61x | CN¥836.53 Million | CN¥622.77 Million | CN¥1.36 Billion | ▲ +140.4% |
| 2020 | 0.26x | CN¥293.37 Million | CN¥138.93 Million | CN¥1.15 Billion | ▼ -7.7% |
| 2019 | 0.28x | CN¥379.49 Million | CN¥251.16 Million | CN¥1.37 Billion | ▼ -23.9% |
| 2018 | 0.36x | CN¥470.26 Million | CN¥326.78 Million | CN¥1.29 Billion | ▼ -17.2% |
| 2017 | 0.44x | CN¥494.19 Million | CN¥369.91 Million | CN¥1.13 Billion | ▼ -26.6% |
| 2016 | 0.60x | CN¥479.47 Million | CN¥338.28 Million | CN¥801.23 Million | ▲ +172.6% |
| 2015 | 0.22x | CN¥268.82 Million | CN¥192.25 Million | CN¥1.22 Billion | ▼ -70.2% |
| 2014 | 0.74x | CN¥300.14 Million | CN¥100.60 Million | CN¥407.63 Million | ▼ -21.4% |
| 2013 | 0.94x | CN¥222.85 Million | CN¥110.95 Million | CN¥238.04 Million | ▼ -35.9% |
| 2012 | 1.46x | CN¥219.80 Million | CN¥142.38 Million | CN¥150.41 Million | ▼ -47.2% |
| 2011 | 2.77x | CN¥255.96 Million | CN¥70.56 Million | CN¥92.54 Million | ▲ +66.5% |
| 2010 | 1.66x | CN¥158.74 Million | CN¥91.72 Million | CN¥95.53 Million | ▲ +45.7% |
| 2009 | 1.14x | CN¥123.73 Million | CN¥100.89 Million | CN¥108.46 Million | ▲ +76.1% |
| 2008 | 0.65x | CN¥92.35 Million | CN¥72.86 Million | CN¥142.53 Million | ▲ +44.4% |
| 2007 | 0.45x | CN¥75.02 Million | CN¥49.35 Million | CN¥167.17 Million | ▲ +147.3% |
| 2006 | 0.18x | CN¥27.75 Million | CN¥17.91 Million | CN¥152.93 Million | — |